Progress on the impact of lipid metabolism reprogramming on resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer

XIAO Xinyao, GUO Shunyao, LU Haiyan, SHEN Hua

Abstract: Non-small cell lung cancer (NSCLC) is the main type of lung cancer, accounting for 85% to 90% of cases. The use of epidermal growth factor receptor tyrosine    ...

Chin J Clin Res,2024,37(1):1-5.  [PDF]

Role and mechanism of mast cells in solid tumors

LUO Yang, ZHANG Qing, ZHANG Shu, ZHANG Jianguo, LIU Yifei

Abstract: Mast cells are a type of innate immune cells, and have long been considered to be related to the pathogenesis of allergic and autoimmune diseases. However, in recent years, a number of studies have found that mast cells play  ...

Chin J Clin Res,2024,37(1):6-11.  [PDF]

• Effect of circulating tumor DNA on individualized treatment of non-small cell lung cancer

  CAI Ruoxue, ZHOU Guoren

  Chin J Clin Res,2024,37(1):12-14,19. [PDF]
  
  

• Research advances on the association of nicotinic acetylcholine receptor-related genes and their

  polymorphisms with lung cancer

  LI Yixuan, ZHOU Jing, ZHANG Jing, XIAO Sha

  Chin J Clin Res,2024,37(1):15-19.  [PDF]

• Research progress of lung cancer complicated with pulmonary embolism

  BAI Tuanli, LI Zhenkun

  Chin J Clin Res,2024,37(1):20-23. [PDF]
  
  

• Clinical and molecular pathological characteristics of 371 cases of malignant pulmonary nodules

  LU Xiaomin, WANG Xiao, ZHEN Haiwen, SUN Yi, ZHU Jiping

  Chin J Clin Res,2024,37(1):24-28. [PDF]

• Effects of tislelizumab combined with platinum-containing dual-drug regimen in elderly patients with

  advanced lung adenocarcinoma

  WANG Fei, LIU Pei, PU Jiaze, YU Jun

  Chin J Clin Res,2024,37(1):29-33. [PDF]

  
  

• Impacts of hyperfractionated radiotherapy at different fractionated doses on short- and long-term efficacy

  and toxicity in patients with limited stage small cell lung cancer

  XU Yan, ZHAO Shien, YU Changxu, YE Xin, WEI Shihong

  Chin J Clin Res,2024,37(1):34-38. [PDF]

• Proteomics-based screening and validation of key targets in chronic obstructive pulmonary disease

  complicated with lung cancer

  MA Hongxia, LI Fengsen

  Chin J Clin Res,2024,37(1):39-45. [PDF]

• Meta-analysis of incidence and risk factors of immune checkpoint inhibitor-associated pneumonia in

  patients with lung cancer

  LI Xin, GAO Guozhen, FENG Peiyu, LI Hanyue, PENG Jing

  Chin J Clin Res,2024,37(1):46-51. [PDF]

• CT manifestations and clinical characteristics of pulmonary invasive mucinous adenocarcinoma

  WANG Baoming, DAI Chen, MA Dongchun

  Chin J Clin Res,2024,37(1):52-56. [PDF]

  
  

• Analysis of risk factors for delayed postoperative discharge of patients with pulmonary nodules

  LUO Wei, QU Haoran, YIN Anqi, ZHANG Lidong

  Chin J Clin Res,2024,37(1):57-60. [PDF]

  
  

• Effects of nerve block in different areas on opiate dosage and stress response in patients undergoing

  thoracoscopic radical resection of lung cancer

  HUANG Yibo, WANG Meifang, HE Teng, PU Jianfeng

  Chin J Clin Res,2024,37(1):61-65. [PDF]